A Putative Oral Vaccine based on Live Lactococci Expressing the Surface Glycoproteins Respiratory Syncytial Virus.
Although 50 years have elapsed since the discovery of respiratory syncytial virus (RSV), it remains the primary cause of lower respiratory tract disease in children worldwide without a licensed vaccine which is of utmost priority. On the other hand, bacterial surface display has, in the last two dec...
Saved in:
Main Author: | Lim, Erin Swee Hua |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2010
|
Online Access: | http://psasir.upm.edu.my/id/eprint/22121/1/IB%202010%207R.pdf http://psasir.upm.edu.my/id/eprint/22121/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of two Salmonella-based oral vaccines against human respiratory syncytial virus
by: Jalilian, F. Azizi, et al.
Published: (2015) -
Development of Salmonella-based DNA vaccine against respiratory syncytial virus.
by: Suhaimi, Siti Syazani
Published: (2011) -
Development of a Novel Oral Vaccine Against Human Resipratory Syncytial Virus
by: Jalilian, Farid Azizi
Published: (2011) -
Global respiratory syncytial virus-related infant community deaths
by: Mazur, Natalie, et al.
Published: (2021) -
Dynamics of the bacterially expressed conserved immunogenic region of the human respiratory syncytial virus G protein.
by: Jalilian, Farid Azizi, et al.
Published: (2011)